*** Important Disclaimer : Selecting stocks for trading or investing is completely your decision.
InvestinStocks.co.in provides data, only for educational purpose. Please check various sources for latest data of each stock.
You must consult professional financial expert before buying or selling any stock.
.
Sun Pharma Share price Data
*** Stock Price, volume and % Change is from NSE/BSE. Market cap is from Google.
19-Oct-2026 – Monday.
Sun Pharma share price is down -0.9% on 19-Oct-2026, Mon. 829.45k shares traded. Sun Pharma current market price is Rs 1743 and Sun Pharma present Market capitalization is 418509.3 Crores (approx).
The stock is down -1.0% in 7 days,
down -5.1% in 1 month and
down -8.3% in 2 months.
Sun Pharma results June 2026 (Standalone_YoY) Sun Pharma revenue elevated to 5741 crores up 2% in June 2026 quarter, compared with 5602 crores in June 2025. Sun Pharma Net profit is 1115 crores up 47% in June 2026 quarter, compared with 754 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
*** Data is only for information. Not buy/sell advice.
Last 7 days trading Data:
19-10-26, Mon: 1743 | 829.45k | -0.90%
16-10-26, Fri: 1758.8 | 1.52m | -0.29%
15-10-26, Thu: 1764 | 1.38m | 1.01%
14-10-26, Wed: 1746.4 | 1.81m | -1.37%
13-10-26, Tue: 1770.7 | 1.19m | 0.61%
12-10-26, Mon: 1760 | 1.14m | 0.00%
09-10-26, Fri: 1760 | 1.35m | 0.01%
Data update: 7pm(IST).
Please click below image link for Latest Data.
*** Data is only for info. Not buy/sell advice.
#sunpharma
Click Image for Data | Scroll down for Comments.
About Sun Pharma…
Sun Pharma Founded: 1983, Vapi
Sun Pharma Founder: Dilip Shanghvi
Sun Pharma Headquarters: Goregaon, Mumbai
Sun Pharma Number of employees: 41,000 (2023)
Sun Pharma Revenue: 44,520 crores INR (US$5.6 billion, 2023)
Sun Pharma Subsidiaries: Ranbaxy Laboratories,
Sun Pharmaceutical Industries Ltd. is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients.
Sun Pharma was founded in 1983 in Vapi by Dilip Shanghvi. It is headquartered in Mumbai and has subsidiaries including Ranbaxy Laboratories and Taro Pharmaceutical Industries Ltd..
Sun Pharma is one of the world’s largest generic pharmaceutical companies and the number one specialty generic pharmaceutical company in India. They offer high-quality, affordable medicines to customers and patients in over 100 countries.
Some of Sun Pharma’s products include:
Volini, Revital, Neurobion, Zandu, Vicks, Abzorb, Evion.
Sun Pharma’s CSR efforts focus on serving underprivileged communities and their priority areas include health, education, drinking water, and sanitation.
.
* About Sun Pharma information is from various sources on the internet.
( March 2024 ).
Please verify the official website of Sun Pharma for the latest updated information.
Please visit
https://investinstocks.co.in/find-any-stock-of-Indian-stock-market/
to know about any company.
.
What’s your view on this stock? Please comment.
*Data is only for info. Not Buy or Sell advice.
*** Don’t waste your hard earned money by trading in stock market.
Don’t trade.
100% of the traders will loose money in the market.
“Invest in stock market.”
Consult financial expert before investing.
.
Results Declared Stocks 2026 Jun
From Sun Pharmaceutical Industries Limited website :
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 5.1 billion. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Diversified Specialty and Generics Portfolio
We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Our broad portfolio of more than 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
Every year, we sell over 30 billion doses covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology and respiratory among others.
Driven by Innovation
The first among Indian pharmaceutical companies to realise and embrace the importance of investing in research, we invest up to 7-8% of our global revenues into Research and Development (R&D) every year.
Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development.
Our capabilities extend beyond the development of differentiated products, including liposomal products, inhalers, lyophilized injections, nasal sprays, and controlled release dosage forms.
Our R&D team comprises over 2,700 people.
Global Footprint
From humble beginnings in 1983, Sun Pharma has grown to become one of the largest generic pharmaceutical companies worldwide. We are the largest pharmaceutical company in India.
In the US, we are among the top 10 generic pharmaceutical companies and are ranked second by prescriptions in the generic dermatology market.
We are the largest Indian company in emerging markets with a presence in over 80 markets. Brazil, Mexico, Russia, Romania and South Africa are some of our key emerging markets.
We are present across all major markets in Western Europe, Canada, Australia, New Zealand, Japan and China among others.
Our presence in emerging markets and the developing world enables our teams to cross-sell and build brands with ease.
Please encourage real Data. Please Share.
.
Sun Pharma share price is down -0.9% on 19-Oct-2026, Mon. 829.45k shares traded. Sun Pharma current market price is Rs 1743 and Sun Pharma present Market cap is 418509.3 Crores (approx). The stock is down -1.0% in 7 days, down -5.1% in 1 month and down -8.3% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is down -0.29% on 16-Oct-2026, Fri. 1.52m shares traded. Sun Pharma current market price is Rs 1758.8 and Sun Pharma present Market cap is 421995.1 Crores (approx). The stock is down -1.2% in 7 days, down -5.1% in 1 month and down -6.5% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is up 1.01% on 15-Oct-2026, Thu. 1.38m shares traded. Sun Pharma current market price is Rs 1764 and Sun Pharma present Market cap is 423242.7 Crores (approx). The stock is down -2.2% in 7 days, down -3.9% in 1 month and down -8.6% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is down -1.37% on 14-Oct-2026, Wed. 1.81m shares traded. Sun Pharma current market price is Rs 1746.4 and Sun Pharma present Market cap is 419444.6 Crores (approx). The stock is down -1.9% in 7 days, down -4.8% in 1 month and down -9.5% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is up 0.61% on 13-Oct-2026, Tue. 1.19m shares traded. Sun Pharma current market price is Rs 1770.7 and Sun Pharma present Market cap is 424289.3 Crores (approx). The stock is down -1.7% in 7 days, down -3.5% in 1 month and down -8.3% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is down 0% on 12-Oct-2026, Mon. 1.14m shares traded. Sun Pharma current market price is Rs 1760 and Sun Pharma present Market cap is 422283 Crores (approx). The stock is down -3.1% in 7 days, down -4.3% in 1 month and down -9.5% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is up 0.01% on 09-Oct-2026, Fri. 1.35m shares traded. Sun Pharma current market price is Rs 1760 and Sun Pharma present Market cap is 422283 Crores (approx). The stock is down -5.6% in 7 days, down -5.6% in 1 month and down -9.5% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is down -1.19% on 08-Oct-2026, Thu. 1.61m shares traded. Sun Pharma current market price is Rs 1759.8 and Sun Pharma present Market cap is 420308 Crores (approx). The stock is down -4.3% in 7 days, down -6.7% in 1 month and down -9.5% in 2 months.
Please click below image for latest data.
.
Sun Pharma share price is down -1.28% on 07-Oct-2026, Wed. 1.15m shares traded. Sun Pharma current market price is Rs 1781 and Sun Pharma present Market cap is 427682.9 Crores (approx). The stock is down -3.8% in 7 days, down -6.0% in 1 month and down -8.4% in 2 months.
Please click below image for latest data.
.
Please Donate
.
I’m working 24X7 for India to encourage investment in India.
(updating more than 5000 companies stock value data, analyzed data and their results data daily).
Please help me by donating something. help me Here..
Jai Hind.
I’m requesting the same to all the companies, whose data is been served to Investors, daily, forever. Thank you.
Helping the deserved is reaching God level!
.
.
Latest analyzed data updates daily at 7pm(IST).
Add this page to your ‘Home screen’.
Computers: Select Star (Add Bookmark).
.
Mobiles: Select Options (3 dots at top)
Select Open in chrome.
Select Star (Add Bookmark).
.
.
.
.
Latest analyzed Data available
from 7pm – 9am IST
InvestinStocks.co.in
Stock market rare data of India from Nifty – NSE, Sensex – BSE.
* Data is Only for educational purpose, not for trading.
* Please verify Data with latest sources.
* Consult your financial advisor before trading or investing in any stock.
.
Post Sun Pharma Data to social media.
*Please click share button, Copy and paste below text to Content of the post.
Share price content:
Sun Pharma share price is down -0.9% on 19-Oct-2026, Mon. 829.45k shares traded. Sun Pharma CMP is Rs 1743 and Sun Pharma present Mcap is 418509.3 Crs (approx)…
*** Data is only for info. Not buy/sell advice.
#sunpharma
********************************************************
*Please click share button, Copy and paste below text to Content of the post.
Results content:
Sun Pharma results June 2026 (Standalone_YoY) Sun Pharma revenue elevated to 5741 crores up 2% in June 2026 quarter, compared with 5602 crores in June 2025. Sun Pharma Net profit is…Pls click site link for Latest Data.
*** Data is only for info. Not buy/sell advice.
#sunpharma
*Click share button below, Copy and paste above text to Content of the post.
From Mahendra Bolla
